Table 4 Clinical symptoms of the study subjects at baseline and after the 12-weeks of intervention

Pelvic pain

Before

5 (4, 8)

5 (4, 7)

−0.29

−1.63

1.04

0.63^c

After

4 (3, 5)

4 (3, 6)

0.42

−0.04

0.88

0.07^b

Change

−1 (−2, 0)

−1 (−1, 0)

0.5

−0.11

1.12

0.13^c

P-within^**

0.001

 < 0.001

Dyspareunia

Before

6 (3, 8)

6 (3, 7)

−0.34

−1.87

1.17

0.61^c

After

4 (3, 6)

4 (3, 7)

0.82

0.12

1.52

0.02^b

Change

−2 (−2, 0)

−1 (−1, 0)

0.89

0.05

1.73

0.05^c

P-within^**

0.001

0.001

Dyschezia

Before

4 (3, 6)

3 (3, 5)

−0.48

−1.5

0.54

0.33^c

After

3 (2, 4)

3 (2, 4)

1.06

0.46

1.6

0.001^b

Change

−2 (−3, 1)

0 (−1, 0)

1.09

0.47

1.71

0.001^c

P-within^**

 < 0.001

0.002